It has been suggested that association between IL-6 and progression to type 2 diabetes may reflect an attempt to counter-regulate the low-grade inflammation induced by other inflammatory mediators such as TNFα [170]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.